8OJP

Human galectin 1 in complex with inhibitor

8OJP の概要

• エントリーDOI: 10.2210/pdb8ojp/pdb
• 分子名称: Galectin-1, (2~{R},3~{R},4~{S},5~{R},6~{R})-2-[3,5-bis(chloranyl)-4-fluoranyl-phenyl]sulfanyl-6-(hydroxymethyl)-4-[4-(1,3-thiazol-2-yl)-1,2,3-triazol-1-yl]oxane-3,5-diol, GLYCEROL, ... (4 entities in total)
• 機能のキーワード: galectin, ligand, complex, sugar binding, sugar binding protein
• 由来する生物種: Homo sapiens (human)
• タンパク質・核酸の鎖数: 2
• 化学式量合計: 30996.87

構造登録者

Hakansson, M.,Diehl, C.,Nilsson, U.J.,Zetterberg, F.R.,Peterson, K. (登録日: 2023-03-24, 公開日: 2024-06-12, 最終更新日: 2024-10-23)

主引用文献

Zetterberg, F.R.,Diehl, C.,Hakansson, M.,Kahl-Knutson, B.,Leffler, H.,Nilsson, U.J.,Peterson, K.,Roper, J.A.,Slack, R.J.
Discovery of Selective and Orally Available Galectin-1 Inhibitors.
J.Med.Chem., 66:16980-16990, 2023

PubMed Abstract: A new series of orally available α-d-galactopyranosides with high affinity and specificity toward galectin-1 have been discovered. High affinity and specificity were achieved by changing six-membered aryl-triazolyl substituents in a series of recently published galectin-3-selective α-d-thiogalactosides (e.g., GB1107 galectin-1/3 3.7/0.037 μM) for five-membered heterocycles such as thiazoles. The in vitro pharmacokinetic properties were optimized, resulting in several galectin-1 inhibitors with favorable properties. One compound, GB1490 ( galectin-1/3 0.4/2.7 μM), was selected for further characterization toward a panel of galectins showing a selectivity of 6- to 320-fold dependent on galectin. The X-ray structure of GB1490 bound to galectin-1 reveals the compound bound in a single conformation in the carbohydrate binding site. GB1490 was shown to reverse galectin-1-induced apoptosis of Jurkat cells at low μM concentrations. No cell cytotoxicity was observed for GB1490 up to 90 μM in the A549 cells. In pharmacokinetic studies in mice, GB1490 showed high oral bioavailability (% > 99%).

PubMed: 38059452
DOI: 10.1021/acs.jmedchem.3c01787

実験手法

X-RAY DIFFRACTION (1.71 Å)